Stock-Based Compensation (Tables)

12 Months Ended

Oct. 27, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of reconciliation of the number of options outstanding and exercisable

A reconciliation of the number of options outstanding and exercisable as of October 27, 2024, is:

	Shares (in thousands)	Weighted-average Exercise Price		Weighted-average Remaining Contractual Term (Years)	Aggregate Intrinsic Value (in thousands)
Stock Options Outstanding at October 29, 2023	16,384	$	37.61
Granted	1,757	31.46
Exercised	(1,827)	24.28
Forfeited	(61)	42.74
Expired	(259)	37.94
Stock Options Outstanding at October 27, 2024	15,994	$	38.43	4.4	$	5,547
Stock Options Exercisable at October 27, 2024	12,641	$	38.51	3.3	$	5,451

Schedule of weighted-average grant date fair value of stock options granted and the total intrinsic value of options exercised

The weighted-average grant date fair value of stock options granted and the total intrinsic value of options exercised are:

	Fiscal Year Ended
In thousands, except per share amounts	October 27, 2024		October 29, 2023		October 30, 2022
Weighted-average Grant Date Fair Value	$	5.95	$	10.06	$	7.09
Intrinsic Value of Exercised Options	16,259		6,350		109,745

Schedule of weighted-average assumptions used to calculate fair value of each option award

The fair value of each option award is calculated on the date of grant using the Black-Scholes valuation model utilizing the following weighted-average assumptions:

	Fiscal Year Ended
	October 27, 2024		October 29, 2023		October 30, 2022
Risk-free Interest Rate	4.1	%	3.5	%	1.6	%
Dividend Yield	3.6	%	2.4	%	2.4	%
Stock Price Volatility	21.5	%	21.1	%	20.4	%
Expected Option Life	7.5 years		7.4 years		7.5 years

Schedule of reconciliation of the nonvested shares

A reconciliation of the restricted stock units as of October 27, 2024, is:

	Shares (in thousands)	Weighted- average Grant Date Fair Value		Weighted-average Remaining Contractual Term (Years)	Aggregate Intrinsic Value (in thousands)
Restricted Stock Units Outstanding at October 29, 2023	723	$	45.59
Granted	394	31.39
Dividend Equivalents	29	34.94
Vested	(245)	44.78
Forfeited	(18)	43.63
Restricted Stock Units Outstanding at October 27, 2024	882	$	39.22	1.3	$	27,391

A reconciliation of the restricted shares as of October 27, 2024, is:

	Shares (in thousands)	Weighted- average Grant Date Fair Value
Restricted Shares Outstanding at October 29, 2023	44	$	44.14
Granted	54	30.89
Vested	(35)	45.34
Forfeited	(9)	34.44
Restricted Shares Outstanding at October 27, 2024	53	$	31.51

Schedule of the weighted-average grant date fair value and fair value of nonvested shares granted

The weighted-average grant date fair value of restricted stock units granted, the total fair value of restricted stock units granted, and the fair value of restricted stock units that have vested are:

	Fiscal Year Ended
In thousands, except per share amounts	October 27, 2024		October 29, 2023		October 30, 2022
Weighted-average Grant Date Fair Value	$	31.39	$	45.96	$	44.14
Fair Value of Restricted Stock Units Granted	12,355		10,889		15,980
Fair Value of Restricted Stock Units Vested	10,988		8,466		1,893

The weighted-average grant date fair value of restricted shares granted, the total fair value of restricted shares granted, and the fair value of shares that have vested are:

	Fiscal Year Ended
In thousands, except per share amounts	October 27, 2024		October 29, 2023		October 30, 2022
Weighted-average Grant Date Fair Value	$	30.89	$	44.14	$	47.11
Fair Value of Restricted Shares Granted	1,680		1,920		1,760
Fair Value of Restricted Shares Vested	1,600		1,760		1,760